Patients transportation issues

To address the myriad of issues a chemical attack would present to a community, a response template plan with national applicabihfy, referred to as the Off-Site Triage, Treatment and Transport Center, was formulated. The concept was designed to address the non-critical and non-exposed patients who can be expected to seek medical help. This concept requires the set-up of an ancillary medical fadhty to handle the large number of walking wounded and worried well casualties that are expected from a terrorist attack. The facihty would be a temporary site that supplements existing assets, since many of these centers can be set-up as are deemed necessary. The care envisioned to be provided in such a center includes decontamination, initial entry into the medical care system for patients not processed at the scene, care for non-critical patients, transportation to medical facilities for patients in need, and mental health care. 

Take measures to ensure compliance with medications and access to care. Compliance with medication regimens is a common problem for patients with epilepsy. Patients should be asked at every visit how they are taking their medications and if they missed any doses. Identify barriers to care, such as financial issues or transportation problems. 

Issues related to transportation of patients. Guidelines and companion tools related to the development of altered standards of care in a mass casualty event are needed by, and would be extremely... 

With the advances in measurement that promise to continue, knowledgeable clinicians will become the transportation for these measures to inclusion in patient care. Interpretation, it is suggested, is partially an issue of familiarity and repeated applications of the measures would lead to a better understanding. Ideally, a better understanding of what a patient tells their provider about their health status can be used for decision making that requires the patient to more actively and routinely participate in their own care. 

The droplet size distribution of the emulsions may change as a consequence of photochemical reactions in TPN formulations. Physical stability of the emulsion is an important issue for patient safety because coalescence of the disperse phase and a subsequent increase in globule size could result in thrombosis in vivo (Ford, 1988). Thus, stability testing of TPN emulsions should also include size distribution analyses after exposure to irradiation, as described by Williams et al. (1990). Ideally, the emulsion should be formulated so that the disperse droplets have a size distribution corresponding to the chylomicra (500 to 1000 nm), which are the natural transport systems for fat through the blood stream (Ford, 1988). The size of the disperse droplets should not be affected by the storage temperature or exposure to optical irradiation. However, it is important to note that addition of any substance (e.g., a drug) to a photochemically stable TPN preparation may alter the photoreactivity and thus the photochemical stability of the formulation. 

---